Early research (Phase 1)Study completedNCT04323202
What this trial is testing
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N
Who this might be right for
Basal Cell Carcinoma of the Head and Neck
Case Comprehensive Cancer Center 13